<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04419454</url>
  </required_header>
  <id_info>
    <org_study_id>DO609568A</org_study_id>
    <nct_id>NCT04419454</nct_id>
  </id_info>
  <brief_title>Retrospective Evaluation of Cellulite of Laxity Treatment Using Body Tite</brief_title>
  <official_title>Retrospective Evaluation of Cellulite of Laxity Treatment Using Body Tite</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>InMode MD Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>InMode MD Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Retrospective Evaluation of Cellulite of Laxity Treatment Using Body Tite
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this preliminary report is to retrospectively evaluate this novel treatment
      approach to improve the appearance of cellulite on the thighs and buttocks by tightening the
      SFS using RFAL.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 5, 2020</start_date>
  <completion_date type="Anticipated">July 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Photonumeric Cellulite Severity Score</measure>
    <time_frame>[ Time Frame: Baseline to 6 months posttreatment]</time_frame>
    <description>Change in Photonumeric Cellulite Severity Score 3. Investigator assessment of the cellulite improvement comparing pre and post treatment using Global aesthetic improvement 5-point grading scale (0=No change, 1=1%-24%%, 2=25%-49%, 3=50%-74% improvement, and 4=75%-100%) at all follow up visits.</description>
  </primary_outcome>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Cellulite</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BodyTite</intervention_name>
    <description>retrospectively evaluate this novel treatment approach to improve the appearance of cellulite on the thighs and buttocks by tightening the SFS using RFAL.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Sample size will be a result of available charts from a 16-month retrospective review
        January 2018 - May 2019. The sample will not include any vulnerable populations (pregnant
        women, minors, or prisoners)
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age â‰¥ 18years of age at the time of procedure

               -  patients with localized lipodystrophy in the medial or lateral thigh, and visible
                  cellulite of laxity in the lower extremity or buttocks

               -  BodyTite treatments performed from January 2018 - May 2019 for Cellulite
                  indication

        Exclusion Criteria:

          -  active infection, collagen disorders, immunocompromised state, medications that
             mitigate inflammatory response, and propensity for keloid/hypertrophic scaring. o
             BodyTite treatments performed from March 2018 - May 2019 for lipodystrophy and
             cellulite of laxity
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark Petrs, MD</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <location>
    <facility>
      <name>Dr. Mark Peters</name>
      <address>
        <city>Germantown</city>
        <state>Tennessee</state>
        <zip>38138</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 3, 2020</study_first_submitted>
  <study_first_submitted_qc>June 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 5, 2020</study_first_posted>
  <last_update_submitted>July 27, 2020</last_update_submitted>
  <last_update_submitted_qc>July 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cellulite</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

